Users Online: 134 | Home Print this page Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

A comprehensive study on regulatory requirements for development and filing of generic drugs globally

Handoo Shweta, Arora Vandana, Khera Deepak, Nandi Prafulla Kumar, Sahu Susanta Kumar

Year : 2012| Volume: 2| Issue : 3 | Page no: 99-105

   This article has been cited by
 
1 Status and trends in the development of clinical diagnostic agents
Tatjana Opacic,Vera Paefgen,Twan Lammers,Fabian Kiessling
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2016;
[Pubmed]  [Google Scholar] [DOI]
2 BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements
Barbara M. Davit,Isadore Kanfer,Yu Chung Tsang,Jean-Michel Cardot
The AAPS Journal. 2016;
[Pubmed]  [Google Scholar] [DOI]
3 Generic medicines: issues and relevance for global health
Proteesh Rana,Vandana Roy
Fundamental & Clinical Pharmacology. 2015; 29(6): 529
[Pubmed]  [Google Scholar] [DOI]
4 USA FDAs implementation of QbD and GDUFA: A wakeup call for other regulatory agencies across the globe
Manisha Saini,Swagat Tripathy,Harish Dureja
Journal of Medical Marketing. 2014; 14(2-3): 108
[Pubmed]  [Google Scholar] [DOI]

 

Read this article